- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04130581
Brain Stimulation During Arm Immobilisation (ImmobiStim)
February 18, 2020 updated by: Helen Nuttall, Lancaster University
Exercising the Motor Cortex Using Brain Stimulation
The research project explores how non-invasive brain stimulation can be used to detect and ameliorate loss of muscle strength after inactivity.
At present, there is a limited understanding of how to maintain muscle strength during inactivity.
Increasing evidence indicates that reduction in muscle strength following immobilisation is associated with reduced cortical motor output.
Therefore, the aim of the study is to test if brain stimulation, can maintain cortical motor output and ameliorate the loss of muscle strength following immobilisation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Lancashire
-
Lancaster, Lancashire, United Kingdom, LA1 4YF
- Lancaster University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 30 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Male
- right-handed
- aged 18-30
- healthy BMI
Exclusion Criteria:
- no primary muscle disorders
- no open wounds or skin conditions to arms and hands
- no neurological disorders or history of
- no history of fainting/convulsions
- no metal implanted into head/eye/neck
- non-smoker
- no arm, hand, fingers, shoulder injuries
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: TMS
Six 30-pulse trains of 20 Hz repetitive Transcranial Magnetic Stimulation to left primary motor cortex hand area, separated by 60 seconds, repeated at 0, 24, 48, and 72 hours post-immobilisation.
|
TMS is a safe and non-invasive technique, which involves the generation of brief magnetic pulses applied to the head through a coil.
The magnetic pulses pass through the scalp and skull and induce weak electric currents in the neural tissue directly underneath the coil.
When TMS is applied in repetitive, patterned trains of pulses (rTMS), it can induce cortical plasticity specifically in the targeted brain region.
|
Sham Comparator: Sham
Six 30-pulse trains of 20 Hz repetitive sham Transcranial Magnetic Stimulation above, but not in contact with, the head, separated by 60 seconds, repeated at 0, 24, 48, and 72 hours post-immobilisation.
|
TMS is a safe and non-invasive technique, which involves the generation of brief magnetic pulses applied to the head through a coil.
The magnetic pulses pass through the scalp and skull and induce weak electric currents in the neural tissue directly underneath the coil.
When TMS is applied in repetitive, patterned trains of pulses (rTMS), it can induce cortical plasticity specifically in the targeted brain region.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Motor Evoked Potentials (MEPs) across time points
Time Frame: 0, 24, 48, and 72 hours
|
MEPs are elicited via TMS to primary motor cortex and index the excitability of the motor pathway.
They are recorded non-invasively from muscles using surface electrodes.
At each time point of the study (0, 24, 48, 72 hours) record MEPs will be recorded pre and post-intervention from the hand muscles of the dominant (immobilised) arm, and non-dominant (non-immobilised arm), to evaluate changes in excitability.
Specifically, the peak-to-peak value of the MEPs from the hand will be measured, which reflects the amplitude of the MEP response.
The latency of the MEP to index neural conduction speed will also be measured.
|
0, 24, 48, and 72 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in grip strength across time points
Time Frame: 0, and 72 hours.
|
Grip strength of the dominant and non-dominant hands will be assessed using an isokinetic dynamometer at 0 and 72 hrs post-immobilisation.
This will measure the strength of the hand muscles.
|
0, and 72 hours.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 14, 2018
Primary Completion (Actual)
January 31, 2020
Study Completion (Actual)
January 31, 2020
Study Registration Dates
First Submitted
October 15, 2019
First Submitted That Met QC Criteria
October 16, 2019
First Posted (Actual)
October 17, 2019
Study Record Updates
Last Update Posted (Actual)
February 19, 2020
Last Update Submitted That Met QC Criteria
February 18, 2020
Last Verified
February 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- PSA1775
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Muscle Loss
-
United States Army Research Institute of Environmental...US Army Natick Soldier Research, Development & Engineering CenterCompletedMuscle Loss | Muscle Anabolism | Muscle PerformanceUnited States
-
United States Army Research Institute of Environmental...Tufts UniversityCompletedMuscle Loss | Muscle AnabolismUnited States
-
Göteborg UniversityCompleted
-
Gdansk University of Physical Education and SportMedical University of GdanskCompleted
-
Gdansk University of Physical Education and SportMedical University of GdanskCompleted
-
Orient Europharma Co., Ltd.Completed
-
Investigación en Hemofilia y FisioterapiaCompleted
-
The University of Texas Medical Branch, GalvestonNational Space Biomedical Research InstituteCompleted
-
Maastricht University Medical CenterCompleted
-
Zhejiang UniversityHuashan Hospital; West China Hospital; The Affiliated Hospital of Qingdao University and other collaboratorsNot yet recruitingLiver Transplantation | Muscle Loss | Muscle Quality
Clinical Trials on Transcranial Magnetic Stimulation (TMS)
-
Emory UniversityNational Institute of Mental Health (NIMH)Recruiting
-
Centre Hospitalier St AnneNot yet recruitingTreatment Resistant Schizophrenia
-
University of California, San DiegoNational Institutes of Health (NIH)RecruitingMajor Depressive DisorderUnited States, Australia
-
Northwestern UniversityCompletedHealthyUnited States
-
University of FloridaActive, not recruiting
-
Huashan HospitalUnknown
-
University of ManitobaRecruiting
-
University of PennsylvaniaCompletedAttention Deficit Disorder With Hyperactivity (ADHD)United States
-
Beth Israel Deaconess Medical CenterTerminated
-
Northwestern UniversityRecruiting